Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hep.23350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comment on the Article: Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin II receptor blockers: a retrospective cohort study using LIFE Study data.
Hypertens Res
December 2024
Department of General Practice, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
Has APOL1 kidney disease treatment been hiding in plain sight?
Kidney Int
December 2024
Department of Medicine, Division of Nephrology and Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address:
Two coding variants of APOL1 account for much of the excess risk of focal segmental glomerulosclerosis in people of recent West African ancestry. There is an unmet need of treatment for apolipoprotein L1 kidney disease. In this issue, Sula Karreci et al.
View Article and Find Full Text PDFAntihypertensive combinations: mind the potassium.
Hypertens Res
January 2025
Division of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Antihypertensive medications that can affect potassium homeostasis in the body. JGA, juxtaglomerular apparatus; ACEIs, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; MR, mineralocorticoid receptor.
View Article and Find Full Text PDFUnderstanding the etiology of mental health problems in post-rehabilitation COVID-19 patients: Insights and strategies for effective intervention.
World J Clin Cases
August 2024
Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China.
In this editorial, we comment on an article by Alhammad that was published in a recent issue of the (Manuscript No.: 91134). We specifically focus on the mental health problems caused by coronavirus disease 2019 (COVID-19), their mechanisms, and targeted rehabilitation strategies.
View Article and Find Full Text PDFDo angiotensin-converting enzyme inhibitors not reduce the risk of pneumonia?
Hypertens Res
October 2024
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!